However, its benefits extend to other related conditions: Type 2 Diabetes Tirzepatide effectively manages blood sugar levels, reducing the risk of diabetes-related complications such as neuropathy, retinopathy, and kidney disease
Indeed, if tirzepatide and other GLP-1 drugs for weight loss become subject to mandatory discounting through the Inflation Reduction Act (by 2031, or sooner if their developers attempt to reduce prices in anticipation of this deadline) or similar regulation, their prices would be directly reduced, making them more affordable
At higher exposures these findings were associated with moderate to marked adverse clinical signs (lethargy, abnormal respiration, ataxia, reduced activity, body tone and reflexes) and marked decreases in plasma and CSF glucose levels
Fatigue ranked as the second most common complaint among real-world users, despite being poorly flagged in most clinical trial summaries